Related Experiment Video

Updated: Jul 7, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance

Brice Emanuelli1, Delphine Eberlé, Ryo Suzuki

  • 1Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.

Proceedings of the National Academy of Sciences of the United States of America
|February 26, 2008
PubMed

Insights

MAP kinase phosphatase-4 (MKP-4) combats insulin resistance by reducing stress kinase activity. Increased MKP-4 sensitizes insulin signaling, offering a potential therapy for metabolic disorders like type 2 diabetes and obesity.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Research

Background:

  • Insulin resistance, common in type 2 diabetes and obesity, involves heightened MAP and stress-activated protein (SAP) kinase activity, impairing insulin signaling.
  • The specific role of MAP kinase phosphatase-4 (MKP-4) in this process requires elucidation.

Purpose of the Study:

  • To investigate the function of MKP-4 in regulating insulin signaling pathways.
  • To determine MKP-4's potential as a therapeutic target for insulin resistance.

Main Methods:

  • Examined MKP-4 expression during adipocyte/myocyte differentiation and fasting.
  • Overexpressed MKP-4 in 3T3-L1 cells and mouse liver models.
  • Assessed effects on ERK, JNK, p38MAPK phosphorylation, IRS-1 signaling, glucose uptake, and gene expression.

Main Results:

  • MKP-4 expression increased with differentiation and fasting.
  • MKP-4 overexpression inhibited ERK and JNK phosphorylation, enhancing insulin signaling and glucose uptake.
  • In vivo, MKP-4 reduced glycemia, improved glucose tolerance, and decreased hepatic steatosis in ob/ob mice.

Conclusions:

  • MKP-4 protects against insulin resistance by dephosphorylating stress-induced mediators like ERK and JNK.
  • Boosting MKP-4 activity presents a promising therapeutic strategy for insulin-resistant conditions.

More Related Videos

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...